Simeprevir added to peginterferon and ribavirin lessens time with fatigue, depressive symptoms and functional limitations in patients with chronic hepatitis C compared with peginterferon and ribavirin: results from 1161 patients in the QUEST‐1, QUEST‐2 and PROMISE studies
暂无分享,去创建一个
E. Brohan | Jane Scott | M. Fu | W. Jessner | M. Beumont | R. Arbuckle | L. Gilles | C. Panter | J. Scott